Reference : A single infusion of zoledronic acid 5 mg (ZOL) is significantly more effective than ...
Scientific congresses and symposiums : Paper published in a journal
Human health sciences : General & internal medicine
Human health sciences : Public health, health care sciences & services
Human health sciences : Endocrinology, metabolism & nutrition
http://hdl.handle.net/2268/82392
A single infusion of zoledronic acid 5 mg (ZOL) is significantly more effective than daily oral risedronate 5 mg (RIS) in increasing bone mineral density (BMD) of the lumbar spine (LS), hip, femoral neck and trochanter in patients with glucocorticoid-induced osteoporosis (GIO)
English
Reid, D. M. [ > > ]
Devogelaer, Jean-Pierre [ > > ]
Saag, K. [ > > ]
Roux, Christian [ > > ]
Lau, C. S. [ > > ]
Reginster, Jean-Yves mailto [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Papanastasiou, P. [ > > ]
Ferreira, A. [ > > ]
Fashola, T. [ > > ]
Sambrook, P. [ > > ]
Apr-2008
Osteoporosis International
Springer Science & Business Media B.V.
19
Suppl.1
S23-24
Yes (verified by ORBi)
No
International
0937-941X
1433-2965
Godalming
United Kingdom
Eight European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis
du 9 avril 2008 au 12 avril 2008
WHO Collaborating Center for Public Health Aspects of Osteoarticular Disorders, Liège, Belgium and ESCEO
Istanbul
Turkey
http://hdl.handle.net/2268/82392

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
OC43.pdfPublisher postprint259.5 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.